Sublingual grass and ragweed immunotherapy: Clinical considerations - A PRACTALL consensus report

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 2, 2016, Pages 369-376

  Li, James T ^a   Bernstein, David I ^b   Calderon, Moises A ^c   Casale, Thomas B ^d   Cox, Linda ^e   Passalacqua, Giovanni ^f   Pfaar, Oliver ^g,h   Papadopoulos, Nikolaos G ⁱ  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e NOVA SOUTHEASTERN UNIVERSITY   (United States)

^f UNIVERSITY OF GENOA   (Italy)

^g Centre of Rhinology and Allergology   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ Allergy Research Center 41   (Greece)

Author keywords

immunotherapy; ragweed; Sublingual; sublingual immunotherapy

Indexed keywords

GRASS POLLEN EXTRACT; POLLEN EXTRACT; RAGWEED POLLEN EXTRACT; ALLERGEN; ANTIALLERGIC AGENT; PLANT ANTIGEN;

ALLERGIC RHINITIS; ANAPHYLAXIS; COMPARATIVE EFFECTIVENESS; CONSENSUS; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; EUROPE; GASTROINTESTINAL SYMPTOM; HUMAN; MOUTH DISEASE; PHARYNX DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW (TOPIC); UNITED STATES; ADVERSE EFFECTS; AGE; DISEASE MANAGEMENT; IMMUNOLOGY; MEDICATION COMPLIANCE; POACEAE; PROCEDURES; RAGWEED; RHINITIS, ALLERGIC; STANDARDS; TREATMENT OUTCOME;

AGE FACTORS; ALLERGENS; AMBROSIA; ANTI-ALLERGIC AGENTS; ANTIGENS, PLANT; DISEASE MANAGEMENT; HUMANS; MEDICATION ADHERENCE; POACEAE; RHINITIS, ALLERGIC; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 84957933551     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.06.046     Document Type: Article

References (68)

1. RAGWITEKTM (Short Ragweed Pollen Allergen Extract) tablet for sublingual use prescribing information. Available at: http://www.merck.com/product/usa/pi-circulars/r/ragwitek/ragwitek-pi.pdf. Accessed December 26, 2014.
2. GRASTEK® (Timothy Grass Pollen Allergen Extract). Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Allergenics/UCM393184.pdf. Accessed December 14, 2014.
3. ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract). Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Allergenics/UCM391580.pdf. Accessed April 26, 2015.
4. S.Y. Lin, N. Erekosima, J.M. Kim, M. Ramanathan, C. Suarez-Cuervo, Y. Chelladurai, and et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review JAMA 309 2013 1278 1288
5. A. Bufe, P. Eberle, E. Franke-Beckmann, J. Funck, M. Kimmig, L. Klimek, and et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy J Allergy Clin Immunol 123 2009 167 173.e7
6. A.W. Burks, M.A. Calderon, T. Casale, L. Cox, P. Demoly, M. Jutel, and et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report J Allergy Clin Immunol 131 2013 1288 1296.e3
7. D. Di Bona, A. Plaia, M.S. Leto-Barone, S. La Piana, and G. Di Lorenzo Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison J Allergy Clin Immunol 130 2012 1097 1107
8. J. Dretzke, A. Meadows, N. Novielli, A. Huissoon, A. Fry-Smith, and C. Meads Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison J Allergy Clin Immunol 131 2013 1361 1366
9. Y. Chelladurai, C. Suarez-Cuervo, N. Erekosima, J.M. Kim, M. Ramanathan, J.B. Segal, and et al. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review J Allergy Clin Immunol 1 2013 361 369
10. J.M. Kim, S.Y. Lin, C. Suarez-Cuervo, Y. Chelladurai, M. Ramanathan, J.B. Segal, and et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review Pediatrics 131 2013 1155 1167
11. Y. Chelladurai, and S.Y. Lin Effectiveness of subcutaneous versus sublingual immunotherapy for allergic rhinitis: current update Curr Opin Otolaryngol Head Neck Surg 22 2014 211 215
12. S. Radulovic, D. Wilson, M. Calderon, and S. Durham Systematic reviews of sublingual immunotherapy (SLIT) Allergy 66 2011 740 752
13. M.A. Calderon, B. Alves, M. Jacobson, B. Hurwitz, A. Sheikh, and S. Durham Allergen injection immunotherapy for seasonal allergic rhinitis Cochrane Database Syst Rev 1 2007 CD001936
14. A. Meadows, B. Kaambwa, N. Novielli, A. Huissoon, A. Fry-Smith, C. Meads, and et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis Health Technol Assess 17 2013 vi, xi-xiv, 1-322
15. I. Piazza, and N. Bizzaro Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus Ann Allergy 71 1993 461 469
16. T. Quirino, E. Iemoli, E. Siciliani, S. Parmiani, and F. Milazzo Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study Clin Exp Allergy 26 1996 1253 1261
17. D. Mungan, Z. Misirligil, and L. Gurbuz Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma - a placebo controlled study Ann Allergy Asthma Immunol 82 1999 485 490
18. M.S. Khinchi, L.K. Poulsen, F. Carat, C. Andre, A.B. Hansen, and H.J. Malling Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study Allergy 59 2004 45 53
19. M. Mauro, M. Russello, C. Incorvaia, G.B. Gazzola, G. Di Cara, and F. Frati Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study Eur Ann Allergy Clin Immunol 39 2007 119 122
20. C. Antunez, C. Mayorga, J.L. Corzo, A. Jurado, and M.J. Torres Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration Pediatr Allergy Immunol 19 2008 210 218
21. R. Tahamiler, G. Saritzali, S. Canakcioglu, E. Ozcora, and A. Dirican Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis ORL J Otorhinolaryngol Relat Spec 70 2008 144 150
22. M.T. Ventura, A. Carretta, R.A. Tummolo, R. Buquicchio, A. Arsieni, and N. Murgia Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy Int J Immunopathol Pharmacol 22 2009 403 413
23. A.O. Eifan, T. Akkoc, A. Yildiz, S. Keles, C. Ozdemir, N.N. Bahceciler, and et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial Clin Exp Allergy 40 2010 922 932
24. A. Yukselen, S.G. Kendirli, M. Yilmaz, D.U. Altintas, and G.B. Karakoc Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study Int Arch Allergy Immunol 157 2011 288 298
25. S. Keles, E. Karakoc-Aydiner, A. Ozen, A.G. Izgi, A. Tevetoglu, T. Akkoc, and et al. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes J Allergy Clin Immunol 128 2011 808 815.e7
26. K. Aasbjerg, V. Backer, G. Lund, K. Aasbjerg, V. Backer, G. Lund, and et al. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy Clin Exp Allergy 44 2014 417 428
27. P. Devillier, J.F. Dreyfus, P. Demoly, and M.A. Calderon A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis BMC Med 12 2014 71
28. S.R. Durham, W. Emminger, A. Kapp, J.G. de Monchy, S. Rak, G.K. Scadding, and et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial J Allergy Clin Immunol 129 2012 717 725.e5
29. R.C. Strunk, A.L. Sternberg, S.J. Szefler, R.S. Zeiger, B. Bender, and J. Tonascia Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents J Pediatr 154 2009 682 687
30. P.S. Creticos, R.E. Esch, P. Couroux, D. Gentile, P. D'Angelo, B. Whitlow, and et al. Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis J Allergy Clin Immunol 133 2014 751 758
31. K.C. Bergmann, P. Demoly, M. Worm, W.J. Fokkens, T. Carrillo, A.I. Tabar, and et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis J Allergy Clin Immunol 133 2014 1608 1614.e6
32. H. Mosbech, R. Deckelmann, F. de Blay, E.A. Pastorello, E. Trebas-Pietras, L.P. Andres, and et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial J Allergy Clin Immunol 134 2014 568 575.e7
33. H. Nolte, J. Maloney, H.S. Nelson, D.I. Bernstein, S. Lu, Z. Li, and et al. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber J Allergy Clin Immunol 135 2015 1494 1501.e6
34. S.R. Durham, W.H. Yang, M.R. Pedersen, N. Johansen, and S. Rak Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis J Allergy Clin Immunol 117 2006 802 809
35. A. Didier, H.J. Malling, M. Worm, F. Horak, S. Jager, A. Montagut, and et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis J Allergy Clin Immunol 120 2007 1338 1345
36. H. Mosbech, G.W. Canonica, V. Backer, F. de Blay, L. Klimek, L. Broge, and et al. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms Ann Allergy Asthma Immunol 114 2015 134 140.e1
37. A. Didier, M. Worm, F. Horak, G. Sussman, O. de Beaumont, M. Le Gall, and et al. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis J Allergy Clin Immunol 128 2011 559 566
38. J.A. Schwab, H. Wolf, J. Schnitker, and E. Wustenberg Safety and tolerability of an intra-seasonal initiation of the SQ-standardised grass allergy immunotherapy tablet: a non-interventional observational study investigating the feasibility during routine administration Clin Drug Investig 33 2013 719 726
39. K. Reich, C. Gessner, A. Kroker, J.A. Schwab, W. Pohl, H. Villesen, and et al. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis Clin Ther 33 2011 828 840
40. Medication Guide RAGWITEKTM (RAG-wi-tek (Short Ragweed Pollen Allergen Extract). Available at: http://www.merck.com/product/usa/pi-circulars/r/ragwitek/ragwitek-mg.pdf. Accessed May 2, 2015.
41. L.S. Cox, D.L. Linnemann, H. Nolte, D. Weldon, I. Finegold, and H.S. Nelson Sublingual immunotherapy: a comprehensive review J Allergy Clin Immunol 117 2006 1021 1035
42. E. Alvarez-Cuesta, J. Bousquet, G.W. Canonica, S.R. Durham, H.J. Malling, and E. Valovirta Standards for practical allergen-specific immunotherapy Allergy 61 suppl 82 2006 1 20
43. A. Antico, and R. Fante Esophageal hypereosinophilia induced by grass sublingual immunotherapy J Allergy Clin Immunol 133 2014 1482 1484
44. S. Miehlke, O. Alpan, S. Schroder, and A. Straumann Induction of eosinophilic esophagitis by sublingual pollen immunotherapy Case Rep Gastroenterol 7 2013 363 368
45. J. Maloney, D.I. Bernstein, H. Nelson, P. Creticos, J. Hebert, M. Noonan, and et al. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial Ann Allergy Asthma Immunol 112 2014 146 153.e2
46. G. Passalacqua, C.E. Baena-Cagnani, J. Bousquet, G.W. Canonica, T.B. Casale, L. Cox, and et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language J Allergy Clin Immunol 132 2013 93 98
47. L. Cox, D. Larenas-Linnemann, R.F. Lockey, and G. Passalacqua Speaking the same language: the World Allergy Organization subcutaneous immunotherapy systemic reaction grading system J Allergy Clin Immunol 125 2010 569 574.e7
48. M. Makatsori, G.W. Scadding, C. Lombardo, G. Bisoffi, E. Ridolo, S.R. Durham, and et al. Dropouts in sublingual allergen immunotherapy trials - a systematic review Allergy 69 2014 571 580
49. J. Maloney, S. Durham, D. Skoner, R. Dahl, A. Bufe, D. Bernstein, and et al. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma Allergy 70 2015 302 309
50. U. Wahn, L. Klimek, A. Ploszczuk, T. Adelt, B. Sandner, E. Trebas-Pietras, and et al. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study J Allergy Clin Immunol 130 2012 886 893.e5
51. U. Wahn, A. Tabar, P. Kuna, S. Halken, A. Montagut, O. de Beaumont, and et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis J Allergy Clin Immunol 123 2009 160 166.e3
52. M. Blaiss, J. Maloney, H. Nolte, S. Gawchik, R. Yao, and D.P. Skoner Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents J Allergy Clin Immunol 127 2011 64 71 e1-4
53. S. Halken, L. Agertoft, J. Seidenberg, C.P. Bauer, F. Payot, M.F. Martin-Munoz, and et al. Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents Pediatr Allergy Immunol 21 2010 970 976
54. M. Marogna, I. Spadolini, A. Massolo, G.W. Canonica, and G. Passalacqua Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study J Allergy Clin Immunol 126 2010 969 975
55. A. Didier, H.J. Malling, M. Worm, F. Horak, G. Sussman, M. Melac, and et al. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis Clin Exp Allergy 43 2013 568 577
56. E. Novembre, E. Galli, F. Landi, C. Caffarelli, M. Pifferi, E. De Marco, and et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis J Allergy Clin Immunol 114 2004 851 857
57. M. Marogna, D. Tomassetti, A. Bernasconi, F. Colombo, A. Massolo, A.D. Businco, and et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study Ann Allergy Asthma Immunol 101 2008 206 211
58. E. Valovirta, A.K. Berstad, J. de Blic, A. Bufe, P. Eng, S. Halken, and et al. Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with grass pollen-induced allergic rhinoconjunctivitis Clin Ther 33 2011 1537 1546
59. M. Aydogan, A.O. Eifan, S. Keles, T. Akkoc, M.A. Nursoy, N.N. Bahceciler, and et al. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial Respir Med 107 2013 1322 1329
60. G.W. Canonica, L. Cox, R. Pawankar, C.E. Baena-Cagnani, M. Blaiss, S. Bonini, and et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update World Allergy Org J 7 2014 6
61. P.C. Potter, S. Baker, B. Fenemore, and B. Nurse Clinical and cytokine responses to house dust mite sublingual immunotherapy Ann Allergy Asthma Immunol 114 2015 327 334
62. W. Wang, L. Xiang, Y.G. Liu, Y.H. Wang, and K.L. Shen Effect of house dust mite immunotherapy on interleukin-10-secreting regulatory T cells in asthmatic children Chin Med J 123 2010 2099 2104
63. G.W. Canonica, J. Bousquet, T. Casale, R.F. Lockey, C.E. Baena-Cagnani, R. Pawankar, and et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009 Allergy 64 suppl 91 2009 1 59
64. L.S. Cox, C. Hankin, and R. Lockey Allergy immunotherapy adherence and delivery route: location does not matter J Allergy Clin Immunol Pract 2 2014 156 160
65. C. Incorvaia, A. Rapetti, S. Scurati, P. Puccinelli, M. Capecce, and F. Frati Importance of patient's education in favouring compliance with sublingual immunotherapy Allergy 65 2010 1341 1342
66. E. Savi, S. Peveri, G. Senna, and G. Passalacqua Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach Allergy 68 2013 1193 1195
67. B.G. Bender, and J. Oppenheimer The special challenge of nonadherence with sublingual immunotherapy J Allergy Clin Immunol Pract 2 2014 152 155
68. D. Vita, L. Caminiti, P. Ruggeri, and G.B. Pajno Sublingual immunotherapy: adherence based on timing and monitoring control visits Allergy 65 2010 668 669